Financial & competing interests disclosure
Authors are employees and shareholders of Novartis Vaccines Inc. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Additional information
Notes on contributors
![](/cms/asset/d8713da8-efb7-43a1-821c-8d29e802d7fb/ierv_a_1001244_ilg0001_oc.jpg)
Andrew J Geall
![](/cms/asset/b8e25d13-550a-44ee-973a-f335621316db/ierv_a_1001244_ilg0002_oc.jpg)